Spectrum Pharmaceuticals adjourns Annual Meeting of Shareholders to July 1, 2010

NewsGuard 100/100 Score

Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) today announced that it has adjourned its Annual Meeting of Stockholders to 10:30a.m. Pacific Time, Thursday, July 1, 2010, which will be held at the Company's corporate office located at 157 Technology Drive, Irvine, California, 92618. The Company's proxy materials previously filed with the Securities and Exchange Commission on April 28, 2010, and first mailed to the Company's stockholders on or about May 17, 2010, and the proposal being submitted to a vote of the stockholders at the Annual Meeting, as described in such proxy materials, remain unchanged.

The Annual Meeting was adjourned to provide the Company with additional time to solicit proxies from its stockholders to establish the requisite quorum for the conduct of business at the Annual Meeting. A majority of the aggregate of the shares of the Company's common stock and preferred stock that were outstanding as of April 20, 2010, the record date for the Annual Meeting, must be present at the Annual Meeting, either in person or by proxy, to establish a quorum. As of June 18, 2010, approximately 47% of those shares have been voted. The Company encourages those stockholders that held shares of the Company's common stock or preferred stock as of April 20, 2010 to vote their shares.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative levodopa infusion pump trial shows promise for reducing Parkinson's symptoms